These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9463483)
1. Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma. Ismail A; Van Groeningen CJ; Hardcastle A; Ren Q; Aherne GW; Geoffroy F; Allegra CJ; Grem JL Mol Pharmacol; 1998 Feb; 53(2):252-61. PubMed ID: 9463483 [TBL] [Abstract][Full Text] [Related]
2. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells. Geoffroy FJ; Allegra CJ; Sinha B; Grem JL Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251 [TBL] [Abstract][Full Text] [Related]
3. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells. Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189 [TBL] [Abstract][Full Text] [Related]
4. Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks. Wadler S; Horowitz R; Mao X; Schwartz EL Cancer Chemother Pharmacol; 1996; 38(6):529-35. PubMed ID: 8823494 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase. Schwartz EL; Baptiste N; O'Connor CJ; Wadler S; Otter BA Cancer Res; 1994 Mar; 54(6):1472-8. PubMed ID: 8137250 [TBL] [Abstract][Full Text] [Related]
6. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells. Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929 [TBL] [Abstract][Full Text] [Related]
7. Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells. van der Wilt CL; Smid K; Aherne GW; Noordhuis P; Peters GJ Eur J Cancer; 1997 Mar; 33(3):471-8. PubMed ID: 9155534 [TBL] [Abstract][Full Text] [Related]
8. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine. Grem JL; Allegra CJ Biochem Pharmacol; 1991 Jul; 42(2):409-18. PubMed ID: 1713459 [TBL] [Abstract][Full Text] [Related]
9. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells. Houghton JA; Morton CL; Adkins DA; Rahman A Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells. Schwartz EL; Hoffman M; O'Connor CJ; Wadler S Biochem Biophys Res Commun; 1992 Feb; 182(3):1232-9. PubMed ID: 1540167 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line. Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Morikage T; Fujiwara Y; Saijo N Br J Cancer; 1992 Jun; 65(6):857-64. PubMed ID: 1319727 [TBL] [Abstract][Full Text] [Related]
12. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression. Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962 [TBL] [Abstract][Full Text] [Related]
13. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines. Wadler S; Mao X; Bajaj R; Hallam S; Schwartz EL Mol Pharmacol; 1993 Nov; 44(5):1070-6. PubMed ID: 8246910 [TBL] [Abstract][Full Text] [Related]
14. Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells. Grem JL; Nguyen D; Monahan BP; Kao V; Geoffroy FJ Biochem Pharmacol; 1999 Aug; 58(3):477-86. PubMed ID: 10424768 [TBL] [Abstract][Full Text] [Related]
15. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate. Huang Y; Horvath CM; Waxman S Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311 [TBL] [Abstract][Full Text] [Related]
16. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Chu E; Zinn S; Boarman D; Allegra CJ Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502 [TBL] [Abstract][Full Text] [Related]
17. Interferon effects upon fluorouracil metabolism by HL-60 cells. Elias L; Sandoval JM Biochem Biophys Res Commun; 1989 Sep; 163(2):867-74. PubMed ID: 2783128 [TBL] [Abstract][Full Text] [Related]
18. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line. Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882 [TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452 [TBL] [Abstract][Full Text] [Related]
20. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Tillman DM; Petak I; Houghton JA Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]